About this trial
A pilot study to assess the efficacy and feasibility of PBMT for pain control in patients undergoing a TKA and are discharged the same day from an ambulatory surgery center.
Eligibility criteria
Qualifiers
None
Disqualifiers
poorly controlled comorbidities that would not allow surgical intervention such as poorly controlled diabetes (HbA1C > 8.0) renal insufficiency (eGFR <60) poorly controlled CV disease such as CHF that is NYHA class 3 and 4
inability to receive the intervention including contraindications and/or known photosensitivity.
patients with history of total joint infection ever or any infection in the last 6 months
ASA score >3 and Outpatient Arthroplasty Risk Assessment (OARA; medical risk stratification scoring system to help determine day surgery vs inpatient)1 score > 80.
Trial design
Treatments tested in this trial
- LightForce XLI
Treatment groups
Locations
Sponsors and collaborators
Mohammad Burney, MD
Lead sponsor
North Texas Medical Research Institute, PLLC
Sponsor institution
Enovis
Collaborator